Doug Watson, Bhupat Seemar and Ernst Oertel united in view of trainer’s honours as 2022-2023 season reaches its finale
Tennis champion Novak Djokovic has an 80% stake of Danish biotech firm QuantBioRes, which is aiming to develop a medical treatment to counter Covid-19, the company's chief executive told Reuters on Wednesday.
CEO Ivan Loncarevic, who described himself as an entrepreneur, said the investment was made in June 2020 but declined to say how much it was.
QuantBioRes has around 11 researchers working in Denmark, Australia and Slovenia, according to Loncarevic, who stressed they were working on a treatment, not a vaccine.
The company is developing a peptide, which inhibits the coronavirus from infecting the human cell, expects to launch clinical trials in Britain this summer, he added.
A spokesperson for Djokovic did not immediately respond to a request for comment.
The tennis number one has stoked global debate about the rights of people who opt not to get vaccinated after he was deported from Australia on Sunday night, ruling him out of the Australian Open.
ALSO READ:
Doug Watson, Bhupat Seemar and Ernst Oertel united in view of trainer’s honours as 2022-2023 season reaches its finale
Khan struck a sublime 103 from 84 deliveries that was generously peppered with nine boundaries and two sixes
The prime minister spent more than an hour and inspected various works
The campaign aims to distribute 1 billion meals to underprivileged people around the globe during the holy month and beyond
In a candid chat, actress Chitrangada Singh tells Yasser Usman why gaslighting is (almost) the norm in the show business and how she overcame it eventually
The seafront town in Southern Iceland is a visual spectacle one cannot miss
We explore alternative sustainable transportation solutions, besides driving a Tesla
The victim survived for around 10 hours inside the mausoleum